4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-023581
Chief Executive Officer sold 13,000 shares at an average $77.72 ($1,010,357)
- Chief Executive Officer acquired 13,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schenkein David P · Chief Executive Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-04-02 | Exercise or conversion : show line 1 in the form | +13,000 | $0.30 | $3,933 | 13,000 | D |
| 2018-04-02 | Sale : show line 2 in the form | −1,557 | $75.54 | $117,616 | 11,443 | D |
| 2018-04-02 | Sale : show line 3 in the form | −2,600 | $76.40 | $198,640 | 8,843 | D |
| 2018-04-02 | Sale : show line 4 in the form | −3,340 | $77.76 | $259,718 | 5,503 | D |
| 2018-04-02 | Sale : show line 5 in the form | −3,390 | $78.59 | $266,420 | 2,113 | D |
| 2018-04-02 | Sale : show line 6 in the form | −2,113 | $79.49 | $167,962 | 0 | D |
| Open-market sales · 13,000 sh · avg $77.72 · $1,010,357 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-04-02 | Exercise or conversion : show line 7 in the form Stock option (right to buy) | −13,000 | 78,567 | D |
Loading xslF345X03/doc4.xml…